[1]
Dr. Vikram Anant Rajadnya, Dr. Pramod Prabhakar Bhalerao, Dr. Chaitra Vikram Rajadnya, and Dr. Archana Ganesh Dhavalshankh, “COMPARING BRANDS OF GLIBENCLAMIDE(5MG) AND METFORMIN (500MG) SUSTAINED RELEASE(SR) FIXED DOSE COMBINTION (FDC) PREPARATIONS IN HIGHLY COST SENSITIVE INDIAN PATIENTS SCENARIO”., J Popl Ther Clin Pharmacol, vol. 32, no. 8, pp. 1271–1275, Sep. 2025, doi: 10.53555/z6p5cc45.